vulvovaginal candidiasis

Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to vulvovaginal candidiasis: vulvodynia, vulvovaginitis, trichomoniasis, cervicitis, chronic mucocutaneous candidiasis, Oral candidiasis


infection by fungi of the genus Candida, generally C. albicans, most commonly involving the skin, oral mucosa (thrush), respiratory tract, or vagina; occasionally there is a systemic infection or endocarditis. It is most often associated with pregnancy, glycosuria, diabetes mellitus, or use of antibiotics. The Centers for Disease Control and Prevention has found that in the United States this condition is the fourth most common cause of nosocomial infections of the blood stream. Called also candidosis and moniliasis.

The most prominent symptom of vaginitis due to Candida infection is severe itching. Sexual transmission is unlikely. Intravaginal cream containing miconazole or clotrimazole, applied each night for one week, usually clears up the infection. Difficulty or pain with swallowing, or retrosternal pain, may indicate candidiasis of the esophagus. Systemic antifungal therapy is indicated for esophagitis and other more severe forms of the disease. Therapeutic options include ketoconazole, fluconazole, and amphotericin b. Chronic suppressive therapy is sometimes required for severely immunocompromised patients. The Infectious Disease Society of America has published “Practice Guidelines for the Treatment of Candidiasis” on their web site,
atrophic candidiasis oral candidiasis marked by erythematous, pebbled patches on the hard or soft palate, buccal mucosa, and dorsal surface of the tongue, a complication of numerous different conditions such as vitamin deficiency, diabetes mellitus, or poorly fitting dentures. There are acute forms and a chronic form called denture stomatitis.
bronchopulmonary candidiasis candidiasis of the respiratory tree, occurring in a mild afebrile form manifested as chronic bronchitis, and in a usually fatal form resembling tuberculosis. Called also bronchocandidiasis.
chronic mucocutaneous candidiasis a group comprising a number of varying forms of Candida infection, marked by chronic candidiasis of the skin and nails and the mucous membranes of the mouth and vagina that is resistant to treatment; it may be localized or diffuse, is sometimes familial, and may be associated with disorders of the immune and endocrine systems.
endocardial candidiasis Candida endocarditis.
oral candidiasis thrush.
pulmonary candidiasis a type of fungal pneumonia caused by infection with Candida species, seen especially in immunocompromised patients or those with malignancies. Called also Candida pneumonia.
vaginal candidiasis (vulvovaginal candidiasis) candidal infection of the vagina, and usually also the vulva, commonly characterized by itching, creamy white discharge, vulvar redness and swelling, and dyspareunia. Called also Candida or candidal vaginitis and Candida or candidal vulvovaginitis.

vulvovaginal candidiasis

candidal infection of the vagina, and usually also the vulva, commonly characterized by pruritus, creamy white discharge, vulvar erythema and swelling, and dyspareunia. Also called Candida vaginitis, Candida vulvovaginitis, vaginal candidiasis.
References in periodicals archive ?
The scope of the report ranges from global therapeutic landscape of Vulvovaginal Candidiasis to the recent news and deals undertaken in the field of pipeline review.
In another randomized, double-blind, placebo-controlled trial, women with vulvovaginal candidiasis received a standard dose of fluconazole plus probiotics (L.
The epidemiology of vulvovaginal candidiasis among university students.
In addition, human clinical trials recently completed in China show that CZEN 002 is an effective treatment in adult female patients suffering from vulvovaginal candidiasis.
Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severity.
1957 as the world's first antifungal, antibiotic nystatin upstaged newer antifungal agents when used to treat vulvovaginal candidiasis caused by Candida glabrata in sequential, prospective clinical trials.
Approximately three-quarters of all women experience at least one episode of vulvovaginal candidiasis during their lifetime and nearly half of them suffer from multiple episode (1).
A snapshot of the global therapeutic scenario for Vulvovaginal Candidiasis.
Product profiles for marketed products for Vulvovaginal Candidiasis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
Fourteen studies, including 2 randomized clinical trials, 9 case series, and 4 case reports were included in this review of the clinical evidence utilizing intravaginal boric acid for vulvovaginal candidiasis.
In another randomized, double-blind, placebo controlled trial, women with vulvovaginal candidiasis received a standard dose of fluconazole plus probiotics (L.
Pevion Biotech AG today announced results from a large, international survey on the Quality of Life (QoL) of recurrent vulvovaginal candidiasis (RVVC) patients.